Bioptik Technology (4161.TWO) Stock Price

Bioptik Technology Price

CLOSED
22.05
​
Market closed

Revenue has compounded at 12.4% per year over the past 17 years to 837.19 M TWD. Earnings per share have grown at 8.4% per year over the last 16 years. Bioptik Technology's net margin stands at 8.5%, up from 3.1% several years earlier. Bioptik Technology currently offers a dividend yield of about 1.36%. The payout ratio is around 22% of earnings. The dividend has grown at 5.9% per year over the past 3 years.

Bioptik Technology stock price

Access this data via the Eulerpool API

Bioptik Technology business model & stock analysis

Bioptik Technology, Inc. engages in the research and development, manufacture, and sale of hyaluronic acid and skincare product. The company is headquartered in Jhunan, Miaoli. The company went IPO on 2011-07-29. The firm mainly provides multifunctional detectors of blood sugar, cholesterol and uric acid, multifunctional detectors of blood sugar, cholesterol, uric acid and heme, as well as blood sugar, cholesterol, uric acid and heme testing paper products, among others. The firm distributes its medical equipment under the brand names of Easy Mate and Easy Touch. The firm also offers biological and medical cosmetics, including toning lotions, essences, facial masks and face cleaning products. Its cosmetic products are distributed under the brand name of ACUREAL. The firm distributes its products within the domestic market and to overseas markets.

Frequently asked questions about Bioptik Technology

Converted at the current exchange rate, the Bioptik Technology share trades at 0.61 EUR (22.05 TWD).

The revenue cannot currently be calculated for Bioptik Technology.

The profit cannot currently be calculated for Bioptik Technology.

The P/E ratio cannot be calculated for Bioptik Technology at the moment.

The P/S cannot be calculated for Bioptik Technology currently.

The Eulerpool Quality Score for Bioptik Technology is 1/10.

The ISIN of Bioptik Technology is TW0004161005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bioptik Technology is 4161.TWO. The ticker symbol is used to trade Bioptik Technology shares on the stock exchange.

Fair ValueTerminal
19.40 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Jul 29, 2011
ISIN
TW0004161005
Cusip
Y0906R108
Market capitalization
1.32 B TWDSmall Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
7.66
P/B Ratio
1.36
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.59 %
Gross Margin
29.09 %
EBIT Margin
—
Net Margin
8.50 %
EPS (Earnings Per Share)
1.38 TWD
Net Debt / EBIT
—
Debt/Equity
0.11
Dividend
Dividend yield
1.36 %
Payout Ratio
21.71 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
2 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Sep 30, 2026, 9:29 AM

Bioptik Technology Peer Group

Bioptik Technology FIGI

4161:TT (Taipei Stock Exchange) · BBG001WV6HW4